Head and Neck Cancer

PUNE, India, February 26, 2026 The global head and neck cancer therapeutics market is projected to grow from USD...

RARITAN, N.J., Feb. 19, 2026 — Johnson & Johnson announced new Phase 1b/2 clinical data demonstrating that subcutaneous RYBREVANT...

BOSTON, Mass., Feb. 20, 2026 — New clinical findings presented at a major oncology symposium demonstrate that ficerafusp alfa...